Assessment of different folic acid supplementation doses for low-birth-weight infants

Fatma Çakmak Çelik1, Canan Aygün1, Sedat Gülten2

  • 1Division of Newborn, Department of Pediatrics, Ondokuz Mayıs University School of Medicine, Samsun, Turkey.

Turk Pediatri Arsivi
|January 27, 2017
PubMed

Insights

The study found that 25 mcg/day of folic acid is adequate for low-birth-weight infants, as higher doses did not significantly improve folate levels. This dosage ensures sufficient folate for these vulnerable newborns.

Area of Science:

  • Neonatal Nutrition
  • Maternal-Fetal Medicine
  • Nutritional Biochemistry

Background:

  • Low-birth-weight infants are at risk for nutritional deficiencies.
  • Folic acid is crucial for infant development and preventing neural tube defects.
  • Optimal folic acid supplementation for low-birth-weight infants requires investigation.

Purpose of the Study:

  • To determine the adequacy of 50 mcg folic acid supplementation in low-birth-weight infants.
  • To investigate folate levels in mothers, infants, and breast milk.
  • To establish the optimal folic acid dose for low-birth-weight infants.

Main Methods:

  • 141 low-birth-weight infants were randomized into three groups receiving 25, 50, or 75 mcg/day of folic acid.
  • Serum and red cell folate levels were measured at baseline and after supplementation.
  • Maternal serum/red cell folate and breast milk folate levels were also assessed.

Main Results:

  • Infant birth weight averaged 1788.2g and gestational age 33.5 weeks.
  • Maternal folic acid supplementation during pregnancy significantly increased breast milk folate levels.
  • All folic acid supplementation groups showed increased serum folate levels, with no significant inter-group differences.

Conclusions:

  • Folic acid doses of 25, 50, and 75 mcg/day similarly impacted serum folate levels in low-birth-weight infants.
  • A daily dose of 25 mcg/day is considered adequate for low-birth-weight infants.
  • This finding supports evidence-based neonatal nutritional guidelines.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
628
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.7K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
322